Vectura Group PLC (LON:VEC)‘s stock had its “hold” rating reiterated by equities research analysts at Peel Hunt in a research report issued to clients and investors on Friday. They presently have a GBX 160 ($2.02) target price on the stock. Peel Hunt’s price objective indicates a potential upside of 41.84% from the company’s previous close.

Other equities research analysts also recently issued reports about the stock. Royal Bank Of Canada downgraded shares of Vectura Group PLC to an “underperform” rating in a research note on Tuesday, April 25th. Numis Securities Ltd reiterated a “buy” rating and set a GBX 225 ($2.85) price objective on shares of Vectura Group PLC in a research note on Tuesday, April 25th. N+1 Singer downgraded shares of Vectura Group PLC to a “sell” rating in a research note on Monday, April 24th. Stifel Nicolaus reiterated a “buy” rating and set a GBX 225 ($2.85) price objective on shares of Vectura Group PLC in a research note on Tuesday, March 21st. Finally, Citigroup Inc. reiterated a “buy” rating and set a GBX 225 ($2.85) price objective on shares of Vectura Group PLC in a research note on Thursday, March 30th. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of GBX 210.13 ($2.66).

Analyst Recommendations for Vectura Group PLC (LON:VEC)

Shares of Vectura Group PLC (LON:VEC) traded up 0.27% during trading on Friday, reaching GBX 112.80. 6,061,626 shares of the company traded hands. The company has a 50-day moving average of GBX 124.51 and a 200-day moving average of GBX 138.92. The stock’s market capitalization is GBX 764.39 million. Vectura Group PLC has a 12 month low of GBX 110.17 and a 12 month high of GBX 166.97.

TRADEMARK VIOLATION WARNING: “Vectura Group PLC (VEC) Earns “Hold” Rating from Peel Hunt” was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/06/17/vectura-group-plc-vec-earns-hold-rating-from-peel-hunt.html.

Vectura Group PLC Company Profile

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.